Insider · CIK 0002084407
Sally Bridget Lawlor
Files at QNRX (Quoin Pharmaceuticals, Ltd.). First filing Sep 1, 2026, latest Sep 1, 2026.
Sally Bridget Lawlor files SEC Form 4 as CFO at QNRX (Quoin Pharmaceuticals, Ltd.). Since Sep 1, 2026, Sally Bridget Lawlor has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Sep 1, 2026.
A track record needs three past buys with six months of prices behind them; Sally Bridget Lawlor has 0, so none is measured yet.
The newest scored trade: bought $50k of QNRX on Aug 31, 2026, filed Sep 1, 2026, scored 54 (moderate). In the last 12 months: 1 buy worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QNRX: Quoin Pharmaceuticals, Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | Quoin Pharmaceuticals, Ltd. | $50k 10,244 shares | +2328% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase ADSs | +10,244 | $4.88 | $50k | 10,684 | 42 d ago |
| Aug 31, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Ordinary Warrants (Right to Buy)derivative | +5,122 | - | - | 5,122 | 42 d ago |
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +85,250 | $0.00 | $0 | 85,250 | Feb 6, 2026 |
| Dec 1, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +10,330 | $0.00 | $0 | 10,330 | Dec 3, 2025 |
Questions about Sally Bridget Lawlor
Answered from the filings on this page, as of the latest one.
Is Sally Bridget Lawlor buying or selling?
In the last 12 months Sally Bridget Lawlor reported 1 open-market buy worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $50k of QNRX on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Sally Bridget Lawlor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sally Bridget Lawlor has 0.
Where does Sally Bridget Lawlor file Form 4?
Sally Bridget Lawlor has filed Form 4 at QNRX (Quoin Pharmaceuticals, Ltd.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.